Trending...
- Financial Independence Group Partners with Carson Group to Provide Life Insurance, Annuities, Disability, and Long-Term Care Solutions
- North Carolina: German Industrial Automation Company to Build U.S. Headquarters in Gaston County with $7.8 Million Investment
- New Epson LabelWorks 2-inch Bulk Label Printers Now Available at DuraFast Label Company
WILMINGTON, N.C., May 5, 2021 /PRNewswire/ -- Isosceles Pharmaceuticals Inc. a biotechnology company dedicated to developing, commercializing, and marketing innovative non-opioid products for the treatment of mild to moderate pain and inflammatory diseases, today announced the appointment of William D. Humphries as its Chief Executive Officer. Mr. Humphries is a highly accomplished executive leader in the pharmaceutical industry with a proven track record leading several global pharmaceutical companies.
"We are excited to welcome Bill for the role of Chief Executive Officer," said Tim Wright, Chairman of Isosceles Board of Directors. "His extensive background in the pharmaceutical industry will provide invaluable leadership as Isosceles achieves its strategic growth milestones."
Most recently, Mr. Humphries served as President of Ortho Dermatologics, a subsidiary of Bausch Health Companies. He has also held global executive leadership positions at Merz North America, GlaxoSmithKline, Stiefel, and Allergan.
"I would like to thank Tim and the Isosceles team for welcoming me to company," said Mr. Humphries, Chief Executive Officer of Isosceles. "I was attracted to Isosceles by their focus on the pursuit of innovative solutions for safe, novel non-opioid pain relief and the passion the team has for delivering these important products to the market. I look forward to leveraging my experience to accelerate the company's development plans and lead Isosceles as it unlocks its full potential."
More on ncarol.com
Mr. Humphries currently serves as Chairman of the Board at Clearside Biomedical, Chairman of the North Carolina State University Global Luxury Management Board, is a member of the Board at Aclaris Therapeutics, and a member of the Board at Strata Skin Sciences. He received his MBA from Pepperdine University and completed his undergraduate studies at Bucknell University.
About Isosceles Pharmaceuticals, Inc.
Isosceles Pharmaceuticals is a preclinical stage biotechnology and medical device company focused on the delivery of drug master file backed synthetic cannabinoids for their anti-inflammatory and pain relief properties. The Company's proprietary formulations coupled with unique delivery platforms provide high bioavailability via parenteral and transdermal routes.
Investor Contact
Brett Lanier
[email protected]
SOURCE Isosceles Pharmaceuticals, Inc.
Related Links
www.isoscelespharma.com
"We are excited to welcome Bill for the role of Chief Executive Officer," said Tim Wright, Chairman of Isosceles Board of Directors. "His extensive background in the pharmaceutical industry will provide invaluable leadership as Isosceles achieves its strategic growth milestones."
Most recently, Mr. Humphries served as President of Ortho Dermatologics, a subsidiary of Bausch Health Companies. He has also held global executive leadership positions at Merz North America, GlaxoSmithKline, Stiefel, and Allergan.
"I would like to thank Tim and the Isosceles team for welcoming me to company," said Mr. Humphries, Chief Executive Officer of Isosceles. "I was attracted to Isosceles by their focus on the pursuit of innovative solutions for safe, novel non-opioid pain relief and the passion the team has for delivering these important products to the market. I look forward to leveraging my experience to accelerate the company's development plans and lead Isosceles as it unlocks its full potential."
More on ncarol.com
- Scallop Software is now a GSA MULTIPLE SCHEDULE approved vendor. Congratulations from Brian Peterson and the Government Marketplace LLC team
- Overlooked Hurricane Katrina Mississippi Black Women Survivors Resilience and Recovery
- North Carolina: Op-Ed for Publication from Governor Cooper: Your Shot at a Million, Our Shot at Defeating the Pandemic for Good
- Ingersoll Rand to Virtually Participate in Fireside Chat Hosted by Barclays
- North Carolina: Governor Cooper Proclaims June 19 as Juneteenth Day
Mr. Humphries currently serves as Chairman of the Board at Clearside Biomedical, Chairman of the North Carolina State University Global Luxury Management Board, is a member of the Board at Aclaris Therapeutics, and a member of the Board at Strata Skin Sciences. He received his MBA from Pepperdine University and completed his undergraduate studies at Bucknell University.
About Isosceles Pharmaceuticals, Inc.
Isosceles Pharmaceuticals is a preclinical stage biotechnology and medical device company focused on the delivery of drug master file backed synthetic cannabinoids for their anti-inflammatory and pain relief properties. The Company's proprietary formulations coupled with unique delivery platforms provide high bioavailability via parenteral and transdermal routes.
Investor Contact
Brett Lanier
[email protected]
SOURCE Isosceles Pharmaceuticals, Inc.
Related Links
www.isoscelespharma.com
Filed Under: Business
0 Comments
Latest on ncarol.com
- Is A Licensed Property Manager Required In Nevada?
- 7-Year Old Singer/Songwriter Kyra Pesebre Releases "I Love You, Dad" In Time For Father's Day
- North Carolina: PHOTOS/FOOTAGE AVAILABLE: Governor Cooper Discusses Your Shot at a Million Vaccine Cash Drawing in Davidson County
- The KIS Foundation, Inc. Celebrates World Sickle Cell Day "Day of Physical Fitness and Education"
- Industry Leaders Spotlight the New Payer Regulatory and Compliance Environment at Beacon Leadership Summit
- Arch MI Secures Over $616 Million of Indemnity Reinsurance through Bellemeade Re Insurance-Linked Note Transaction and Related Reinsurance
- Batteries Plus Inks Largest Franchise Deal in Company History
- North Carolina: Lotus Bakeries to Expand in Alamance County Creating Up to 90 Jobs in Mebane
- St Pete Talk joins the Canadian Snowbird Association talking Taxes | Snowbirds
- APX Founder Terri Ross Returns as a Featured Speaker at the 2021 AmSpa Medical Spa & Aesthetic Bootcamps
- OpenSSL 3.0 Release Candidate now available
- Protopia and University of Michigan Host Webinar on AI-Powered Networking in the Classroom
- Lineus Medical Expands US Distribution with CoMedical
- N-able Announces New Addition to Its Executive Leadership Team, Naming Jeff Nulsen as Chief Marketing Officer
- Scandia Inc. Announces Acquisition of Xtreme Organics Inc. To Expand Growth In Medicinal Chemicals And Botanical Products Space
- Ismail Sirdah's Tips for Finding the Perfect concert Venue
- Hyperion Commences Sustainability Life-Cycle Studies
- North Carolina: Governor Cooper Signs Five Bills into Law
- PEI Named Top Managed Services Provider in the United States
- ActivePipe empowering brokerages to stay relevant